Anamorelin demonstrated improvements in lean body mass, body weight, and appetite in patients with cachexia in phase II/III clinical trials [25–28], and it also increased prealbumin, a nutritional state marker, suggesting an improved nutritional status [26, 27]. Here, TTR is linked to Cachexia.